An HIV Vaccine is within reach
An effective, affordable, and accessible HIV vaccine is 7-10 years away, according to scientists at the Medical Research Council of South Africa, in this week’s BMJ. However, its success depends on a complex interplay of politics, science, and public-private partnerships.
Equitable public-private partnerships between researchers, manufacturers, and distributors and partnerships between rich and poor countries are the best strategy for the development of the vaccine, say the authors. Successful vaccine development also entails adequate investment in the countries that carry the burden of the HIV/AIDS pandemic.
Vaccines are the only hope for the control and possible elimination of HIV infection. How we distribute the vaccine will also be a test of our international ethics and humanitarian objectives, they write.
If we fail to provide the world with an effective HIV vaccine, future generations will judge us harshly, because this failure will not be due to lack of ability or resources but to politics, they conclude.
All news from this category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Acute itching in eczema patients linked to environmental allergens
Newly identified pathway explains why antihistamine drugs often don’t work to control severe itch. In addition to a skin rash, many eczema sufferers also experience chronic itching, but sometimes that…
Simulating evolution to understand a hidden switch
Computer simulations of cells evolving over tens of thousands of generations reveal why some organisms retain a disused switch mechanism that turns on under severe stress, changing some of their…